Ignite Creation Date:
2024-05-06 @ 6:44 PM
Last Modification Date:
2024-10-26 @ 2:53 PM
Study NCT ID:
NCT05769075
Status:
RECRUITING
Last Update Posted:
2023-04-24
First Post:
2023-02-09
Brief Title:
A Study of TY-2136b in Patients With Advanced Solid Tumors Harboring ALK ROS1 or NTRK1-3 Alterations
Sponsor:
TYK Medicines Inc
Organization:
TYK Medicines Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-04-20
Start Date Type:
ACTUAL
Primary Completion Date:
2025-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-10
Completion Date Type:
ESTIMATED
First Submit Date:
2023-02-09
First Submit QC Date:
March 2 2023
Study First Post Date:
2023-03-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-04-20
Last Update Post Date:
2023-04-24
Last Update Post Date Type:
ACTUAL